Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://xitter.cf/t.co/CBx3GZBv31
Joined July 2015
- Tweets89.5K
- Following4.7K
- Followers165K
- Likes45K
Pinned Tweet
This year, as in past years, we’ve found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the biggest questions in science and medicine.
Meet the 2026 #STATWunderkinds!
statnews.com/wunderkinds/
“What we don’t know is whether people are disconnecting from one another, gradually, over months of interacting with chatbots,” researchers write. trib.al/rU5iKnd
New guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health. trib.al/OG4a4MQ
The center will study the long-term impact of infections, in addition to RFK Jr.'s focus on vaccines. trib.al/J0aEERU
Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's business strategy. trib.al/fn9nyhn
STAT reporters react to the 'emotional' scenes of Elizabeth Holmes in the ‘You Can See Everything’ documentary.
STAT retweeted
After a cancer vaccine’s first success, the race is on to expand the impact statnews.com/2026/10/25/mrna…
After a cancer vaccine’s first success, the race is on to expand the impact statnews.com/2026/10/25/mrna…
AstraZeneca has seen major momentum in oncology in recent years. It got a big showcase at Europe's top cancer conference. trib.al/Zu2UXXm
MADRID — With the first pivotal trial showing a customized mRNA treatment improved outcomes for cancer patients presented here this weekend, the conversation has already turned to how melanoma specialists… trib.al/P7WcLvg
Moderna and Merck's 'presidential' presentation, and other news from Day 2 of the European Society for Medical Oncology meeting in Madrid. trib.al/BVfeUZc
“Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes a STAT reader. trib.al/sUVV1lK
“The goal is not simply to diagnose MS faster. It is to get the diagnosis right,” writes Bruce Bebo. trib.al/sAmwy2u
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. trib.al/tLLsZMP
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, a new analysis finds. trib.al/c8S5NM0
A special episode of "The Readout LOUD" podcast: Remembering Helen Branswell
Listen: statnews.com/2026/10/23/read…
At last week’s #STATSummit, Dana Senaha told the story of her husband’s experience participating in the clinical trial for daraxonrasib.
Watch: One family’s story of a life-extending medicine for pancreatic cancer
bit.ly/4zVbNnP
The American Diabetes Association has issued two explanations, two reviews and an apology over its June convention. A Friday report adds new twists. trib.al/C2alBV1
The combination of an experimental drug from Tango Therapeutics and Revolution Medicines’ Rasonque led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer. bit.ly/4jyj7Rh
Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early autoimmune trial, adding to safety concerns about a growing field of research. statnews.com/2026/10/23/bris…
In data released at ESMO, the Moderna-Merck personalized mRNA cancer vaccine reduced recurrence-free survival and the time until distant metastasis occurred. trib.al/H25Ow1C
